CHARLESTON, W.Va. (AP) — The U.S. Drug Enforcement Administration has approved a rule change requiring drugmakers to identify a legitimate need for opioids to justify their production in an attempt to rein in their diversion for illicit purposes.
The DEA announced recently that the final rule sent for publication in the Federal Register will consider the extent to which a legally prescribed drug is diverted for abuse when the agency sets its annual opioid production limits.
The rule requires DEA to share notices of proposed aggregate production quotas and final aggregate production quota orders with state attorneys general.
Attorney General Jeff Sessions says the new rule “will allow the DEA to be more responsive to the facts on the ground.”
- Posted July 16, 2018
- Tweet This | Share on Facebook
Rule changes so drugmakers must justify need for opioids
headlines Macomb
- New leadership team takes helm at State Bar
- Governor signs legislation to protect Michigan children, consumers, and communities
- Nessel argues to cut Consumers Energy rate hike in half
- Detroit man bound over on two counts of transporting individuals for prostitution
- Howell man arraigned for allegedly threatening judge
headlines National
- Melissa Hart, the chair of the ABA Legal Ed council, dies
- Judge suspended after indictment over alleged perjury
- Bill Withers’ music publisher files copyright suit over Olivia Dean’s ‘I’ve Seen It’
- Judge reinstates US attorney in Washington fired by Trump
- Interim law dean of University of Florida named to permanent role
- Clio acquires Learned Hand, an AI company for courts, judges
